# Safety and Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy and Fusion

> **NCT01106417** · PHASE1,PHASE2 · COMPLETED · sponsor: **Mesoblast, Ltd.** · enrollment: 12 (actual)

## Conditions studied

- Cervical Degenerative Disc Disease
- Degenerative Spondylolisthesis
- Spinal Stenosis

## Interventions

- **BIOLOGICAL:** NeoFuse
- **DEVICE:** MasterGraft Granules

## Key facts

- **NCT ID:** NCT01106417
- **Lead sponsor:** Mesoblast, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2012-05
- **Final completion:** 2013-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01106417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01106417, "Safety and Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy and Fusion". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01106417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*